SPDR S&P Biotech (XBI)
AMEX
Fin d'année 30 Juin 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 0.268 | 0.209 | -10.221 | 19.149 | 16.522 | -50.021 | 10.103 | 10.172 |
Return on Equity (%) | 0.303 | 0.231 | -11.188 | 21.379 | 18.736 | -55.101 | 11.038 | 11.062 |
Return on Invested Capital (%) | 322.968 | 336.16 | 194.412 | 7.417 | 186.652 | -299.444 | -534.235 | 154.953 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 77.152 | 95.232 | 87.818 | 112.03 | 135.539 | 74.235 | 83.253 | 92.721 |
Earnings Per Share | 0.179 | 0.185 | -10.738 | 21.757 | 22.153 | -42.13 | 9.473 | 9.907 |
Cash Per Share | 0.728 | N/A | N/A | N/A | 0.152 | N/A | N/A | 0.001 |
Working Capital Per Share | 0.092 | 0.033 | 0.011 | 0.154 | 0.105 | 0.023 | 0.011 | 0.034 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | 0.347 | 0.372 | -10.639 | 21.776 | 22.438 | -42.13 | 9.476 | 10.032 |
Fin d'année 30 Juin 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 46M | 54,95M | 50,25M | 48,23M | 53,53M | 92,2M | 77,43M | 74,6M |
Fin d'année 30 Juin 2024 | ||||||||
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 6,89B |
Ratio cours/bénéfice | 9,33 |
Ratio prix/ventes | 270,3 |
Ratio prix/liquidités | 102,74k |
Ratio prix/valeur comptable | 1 |
Rendement de dividende | 14,05% |
Actions en circulation | 74,6M |
Volume moyen (1 semaine) | 6,8M |
Volume moyen (1 mois) | 7,92M |
Variation sur 52 semaines | 4,62% |
Plus haut sur 52 semaines | 105,47 |
Plus bas sur 52 semaines | 81,14 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales